Literature DB >> 12603525

Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection.

Yumiko Nagao1, Shinichiro Hanada, Shyoichiro Shishido, Tatsuya Ide, Ryukichi Kumashiro, Takato Ueno, Michio Sata.   

Abstract

BACKGROUND AND AIM: Hepatitis viruses induce not only chronic liver diseases but also the impairment of other organs and tissues as extrahepatic manifestations. In particular, hepatitis C virus (HCV) is involved in various extrahepatic manifestations. The purpose of the present study was to evaluate Sjögren's syndrome (SS) and lichen planus (LP) involvement, which are various extrahepatic manifestations in patients with liver diseases related to hepatitis B virus (HBV) or HCV.
METHODS: We examined a total of 110 Japanese patients with chronic liver disease: 29 with HBV infections and 81 HCV infections.
RESULTS: The prevalence of SS according to European and Japanese criteria in patients with chronic HCV infection was significantly higher than in patients with chronic HBV infection (European criteria: 25.9 vs 3.4%; P < 0.05, Japanese criteria: 21.0 vs 3.4%; P = 0.05). Lichen planus was observed in one (3.4%) of 29 patients with chronic HBV infection, and in 11 (13.6%) of 81 patients with chronic HCV infection. Simultaneously combined LP and SS occurred in 8.6% (seven of 81) of patients with HCV infection, but in none with HBV infection.
CONCLUSIONS: Clinicians should routinely follow the HCV-infected patients, paying sufficient attention to the presence of SS and LP, and they should also carefully monitor their prognosis.

Entities:  

Mesh:

Year:  2003        PMID: 12603525     DOI: 10.1046/j.1440-1746.2003.02982.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

Review 1.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 2.  Extrahepatic immune related manifestations in chronic hepatitis C virus infection.

Authors:  Maria Tampaki; John Koskinas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Sicca complex among Egyptian patients with chronic hepatitis C virus infection.

Authors:  Zeinab Nawito; Amr Amin; Sohier Abu El-Fadl; Khaled Abu El Einen
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

4.  Anti-SSB/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection.

Authors:  Chien-Sheng Wu; Chung-Yi Hu; Ping-Ning Hsu
Journal:  Clin Rheumatol       Date:  2007-11-09       Impact factor: 2.980

5.  Dental problems delaying the initiation of interferon therapy for HCV-infected patients.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Virol J       Date:  2010-08-17       Impact factor: 4.099

Review 6.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 7.  Hepatitis B virus (HBV) and autoimmune disease.

Authors:  Ram Maya; M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

8.  Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Virol J       Date:  2011-07-12       Impact factor: 4.099

Review 9.  Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Clin Dev Immunol       Date:  2012-09-05

10.  Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases.

Authors:  Yumiko Nagao; Kouji Hashimoto; Michio Sata
Journal:  BMC Gastroenterol       Date:  2012-11-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.